future revenues

Just reading through the DB Healthcare Conference announcement and noticed that 318,000 women per year are diagnosed with ovarian cancer, so I thought Id do some rough calculations as to what that might mean for Prima's future revenue:

Dendreon charge roughly $80,000 if Im not mistaken?

So...if we capture 10% of the market (31,800 women), and charge only $1,000...that equals $31,800,000 gross revenue.

10% market @ $20,000 = $636,000,000 gross revenue

Lets dream a little and imagine:

30% market @ $50,000 = $4,770,000,000 gross revenue

Not bad for a 35c stock with a mc of around $300 million!!!

Then in the announcement they throw this little gem in:

"The Company?s broader, long term goal is to develop commercial cancer treatment technologies
and programs for global markets"

BRING ON NASDAQ LISTING!!!! THE YANKS WILL GET IT.